Creative Medical Technology Holdings, Inc.
CELZ Nasdaq
SEC CIK 1187953
Follow Creative Medical Technology
Weekly email: filings, results
Revenue, last quarter
$0
Net income
−$2.7M
−116% vs same quarter last year
EPS, diluted
−$0.40
+16.7% vs same quarter last year
Operating cash flow
−$1.7M
−42.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $6K | −$6M |
| FY24 | $11K | −$5.5M |
| FY23 | $9K | −$5.3M |
| FY22 | $88.6K | −$10.1M |
| FY21 | $87.8K | $19.2M |
| FY20 | $164.5K | −$36.3M |
| FY19 | $165.5K | −$8.5M |
| FY18 | $124.4K | −$13.7M |
| FY17 | $4.8K | −$2.7M |
| FY16 | $0 | −$766.1K |
| FY15 | $0 | −$30.8K |
| FY14 | $0 | −$28K |
| FY13 | $0 | −$27.3K |
| FY12 | $0 | −$25.6K |
| FY11 | $0 | −$24.1K |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 63.4% | −102380.2% | −99916.8% |
| FY24 | 60% | −52216.9% | −49940.7% |
| FY23 | 60% | −62445.9% | −58739.7% |
| FY22 | 67.8% | −11562.5% | −11449.3% |
| FY21 | 45.4% | −3562.2% | 21892.8% |
| FY20 | 69.2% | −677.7% | −22082.2% |
| FY19 | 72.5% | −682.9% | −5126.1% |
| FY18 | 43.4% | −895.7% | −10977.2% |
| FY17 | −66.7% | −24537.6% | −55398.1% |
| FY16 | - | - | - |
| FY15 | - | - | - |
| FY14 | - | - | - |
| FY13 | - | - | - |
| FY12 | - | - | - |
| FY11 | - | - | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $10K |
| FY24 | $175K |
| FY23 | $271K |
| FY22 | $0 |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | - |
| FY11 | - |
- Creative Medical Technology
- Healthcare median
Show the numbers
| Year | Creative Medical Technology | Healthcare median |
|---|---|---|
| FY25 | −99916.8% | −30.6% |
| FY24 | −49940.7% | −47% |
| FY23 | −58739.7% | −58% |
| FY22 | −11449.3% | −80.4% |
| FY21 | 21892.8% | −71.9% |
| FY20 | −22082.2% | −62.2% |
| FY19 | −5126.1% | −46.3% |
| FY18 | −10977.2% | −49.6% |
| FY17 | −55398.1% | −45.9% |
| FY16 | - | −36% |
| FY15 | - | −38.4% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |
| FY12 | - | −29.1% |
| FY11 | - | −27.9% |